These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19954667)

  • 1. [Establishment of a bone marrow failure mouse model by immune injury].
    Huang LF; Zhou K; Zhang N; Luo L; Zheng M; Zhou S; Sun HY; Liu WL
    Zhonghua Xue Ye Xue Za Zhi; 2009 Oct; 30(10):683-8. PubMed ID: 19954667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of lymphocyte infusion-induced bone marrow failure.
    Bloom ML; Wolk AG; Simon-Stoos KL; Bard JS; Chen J; Young NS
    Exp Hematol; 2004 Dec; 32(12):1163-72. PubMed ID: 15588941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The changes of regulatory T cells and Th17 cells in a novel mouse severe aplastic anemia model].
    Liu HY; Lin ZH; Liu H; Lu W; Zhang YP
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):653-6. PubMed ID: 23134862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating activated suppressor T lymphocytes in aplastic anemia.
    Zoumbos NC; Gascón P; Djeu JY; Trost SR; Young NS
    N Engl J Med; 1985 Jan; 312(5):257-65. PubMed ID: 2981406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The development of immune-mediated aplastic anemia in mice can be blocked by cimetidine].
    Wang M; Liao J; Zhao X; Lin C; Jiang Z; Ma X
    Zhonghua Xue Ye Xue Za Zhi; 2000 Oct; 21(10):527-9. PubMed ID: 11877031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 deficiency augments bone marrow failure in a minor-histocompatibility antigen mismatch lymphocyte infusion model.
    Hollinger MK; Giudice V; Cummings NA; Rivell G; Zhang H; Kajigaya S; Keyvanfar K; Chen J; Feng X; Young NS
    Exp Hematol; 2018 Jun; 62():17-23. PubMed ID: 29524567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hypoplastic marrow failure and residual injury.
    Morley AA; Trainor KJ; Seshadri RS
    Blood Cells; 1978; 4(1-2):253-65. PubMed ID: 371698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologically mediated aplastic anemia in mice: evidence of hematopoietic stromal injury and injury to hematopoietic stem cells.
    Knospe WH; Husseini SG; Chiu KM; Fried W
    Exp Hematol; 1994 Jul; 22(7):573-81. PubMed ID: 8013573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
    Dubey S; Shukla P; Nityanand S
    Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
    Young MR; Wright MA
    Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a CD4+ T cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated aplastic anemia.
    Nakao S; Takamatsu H; Yachie A; Itoh T; Yamaguchi M; Ueda M; Shiobara S; Matsuda T
    Exp Hematol; 1995 May; 23(5):433-8. PubMed ID: 7720814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aplastic anemia following infectious mononucleosis: possible immune etiology.
    Shadduck RK; Winkelstein A; Zeigler Z; Lichter J; Goldstein M; Michaels M; Rabin B
    Exp Hematol; 1979 May; 7(5):264-71. PubMed ID: 314384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
    Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the improvement of bone marrow microenvironment by ligustrazine in immune-induced aplastic anemia mice].
    Sun H; Shu Y; Liu W
    Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):178-80. PubMed ID: 11243129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine natural suppressor cells in the newborn, in bone marrow, and after cyclophosphamide. Genetic variations and dependence on IFN-gamma.
    Maier T; Holda JH; Claman HN
    J Immunol; 1989 Jul; 143(2):491-8. PubMed ID: 2525587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function.
    Sato K; Feng X; Chen J; Li J; Muranski P; Desierto MJ; Keyvanfar K; Malide D; Kajigaya S; Young NS
    Haematologica; 2016 Jan; 101(1):57-67. PubMed ID: 26589913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune aspects of aplastic anemia.
    Baranski BG; Young NS
    In Vivo; 1988; 2(1):91-4. PubMed ID: 2979824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A novel severe aplastic anemia mouse model induced by IFN-γ plus busulphan].
    Ning FY; Lin ZH; Liu H; Chen XF; Sun F; Wang H; Liu HY
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):777-82. PubMed ID: 22339916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proliferative defect of marrow cells in experimental chronic hypoplastic marrow failure (aplastic anaemia).
    Trainor KJ; Morley AA; Seshadri RS
    Exp Hematol; 1980 Jul; 8(6):674-82. PubMed ID: 6451444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic mechanisms in aplastic anemia.
    Finlay JL; Ershler WB; Shahidi NT
    Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.